Picture of Innovent Biologics logo

1801 — Innovent Biologics News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Innovent Biologics Says FY IFRS Revenue Rmb13.04 Billion

March 26 (Reuters) - Innovent Biologics Inc 1801.HK:

FY  IFRS REVENUE RMB13.04 BILLION

Further company coverage: 1801.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Innovent Biologics

See all news